Sort by
Refine Your Search
-
modifying ECM structure our therapies aim to overcome immune exclusion and sensitise tumours to immune-mediated destruction, offering new hope for cancers resistant to current immunotherapy.To achieve
Enter an email to receive alerts for structural-"UCL" positions